Elixion Biotech
Biotechnology Research • 
Zürcherstrasse 39d, Zurich, Switzerland • 1-10 Employees
Company overview
| Headquarters | Zürcherstrasse 39d, Zurich, 8952, CH |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contact at Elixion Biotech
Laurent Deckers
Co-Founder & General Counsel
About Elixion Biotech
Elixion Biotech is a pioneering therapeutic biotechnology company redefining how novel therapies are discovered, designed, and developed. We are among the first biotechs to integrate quantum physics principles across the entire therapeutic development process - from early-stage target identification through clinical trials - with the goal of materially increasing precision at every step. By combining quantum physics-driven insights with cutting-edge biology, Elixion enables the highly accurate prediction of molecular interactions, accelerating discovery timelines and improving clinical success rates — especially in areas of high unmet medical need.
Elixion Biotech revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Elixion Biotech has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Elixion Biotech has never raised funding before.
Czechia
Italy
United Arab Emirates
United States
Frequently asked questions
4.8
40,000 users
